Menu

MyMD Pharmaceuticals, Inc. MYMD

Full chart Compare
Set alert

Price alert · MYMD

All alert types
1.81 +1.81

Day range unavailable

52-week range unavailable

Revenue & Expenses

Revenue → Gross Profit: $127.28KGross Profit → Expenses: $127.28KRevenue → Cost of Revenue: $1.54MExpenses → Selling, General & Admin: $7.45MExpenses → Research & Development: $1.06MExpenses → Other Operating Expenses: $1.68MExpenses → Other Expenses: $788.63KNet Loss → Expenses: $10.85MGross Profit$127.28KNet Loss$10.85MCost of Revenue$1.54MExpenses$10.98MSelling, General & Admin$7.45MResearch & Development$1.06MOther Operating Expenses$1.68MOther Expenses$788.63KRevenue$1.67M

Latest period ending Dec 31, 2023 · select a line to chart its full history

MYMD annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-16.36M-15.28M-28.20M-8.30M-3.47M
-4.00M-15.20M-29.89M-9.49M-3.89M
-5.33-11.74-25.50-10.20-381.00
MYMD annual balance sheet
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
2.68M749.09K555.97K148.28K517.44K
17.86M17.54M24.81M676.70K10.88M
5.09M2.84M1.17M5.93M1.53M
48.87K141.72K149.15K4.13M0
12.37M14.70M23.65M-5.26M9.36M
MYMD annual cash flow
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-12.98M-12.27M-19.52M-4.66M-3.07M
1.85M6.91M19.85M0-3.94M
13.07M5.55M73.53K4.68M6.97M
1.93M193.12K407.68K13.79K-49.22K